William Hope (BMBS, FRACP, FRCPA, PhD), is currently an NIHR Clinician Scientist and Professor of Therapeutics and Infectious Diseases at The University of Liverpool in the United Kingdom. Professor Hope is a Fellow of the Royal Australasian College of Physicians and a Fellow of the Royal College of Pathologists of Australasia.
William Hope qualified in Medicine in 1991 before undertaking specialist training in infectious diseases and clinical microbiology. He completed his PhD in antimicrobial pharmacology in 2006, while undertaking fellowships at The University of Manchester, UK and the National Institutes of Health, Bethesda, USA. He was awarded a Chair in Therapeutics and Infectious Diseases in 2011 at The University of Manchester. He has recently been appointed to a Chair in the Department of Molecular and Clinical Pharmacology at the University of Liverpool.
Dr. Hope’s areas of special interest and research are antimicrobial pharmacokinetics and pharmacodynamics, mathematical modelling of antimicrobial agents, population pharmacokinetics, and individualisation of antimicrobial therapy. Dr Hope is Scientific Advisor to the ESCMID Fungal Infection Study Group (EFSIG), Secretary of the EUCAST Antifungal Susceptibility Testing Sub-Committee and recently appointed to the ICAAC Program Committee for Antimicrobial Pharmacokinetics, Pharmacodynamics and General Pharmacology.